Morepen Laboratories Ltd. Annual stock financials by MarketWatch. View the latest MOREPENLAB financial statements, income statements and financial ratios.

Morepen Laboratories Ltd. announced on Monday (September 8) that its subsidiary, Morepen Medipath Ltd., has signed a joint venture agreement with UAE-based Bimedical FZE. The new entity will be ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...

DUBAI, DUBAI, UNITED ARAB EMIRATES, August 8, 2025 /EINPresswire.com/ -- Morepen Laboratories Limited, a renowned Indian pharmaceutical giant, has successfully ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...

Morepen Laboratories Limited (NSEI:MOREPENLAB) trades with a trailing P/E of 42.2x, which is higher than the industry average of 27.2x. While MOREPENLAB might seem like a stock to avoid or sell if you ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal Dr. Reddy's Laboratories , one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said ...